Search Result for
-
NEWSHow Flu Shot Manufacturing Forces Influenza to Mutate
The new study shows exactly why egg-based manufacturing is a problem for the H3N2 influenza subtype.
-
NEWSNew ResearchKit App from Scripps Research Looks at How Genetic Risk Influences Heart Health Decisions
MyGeneRank app allows individuals with genetic data from 23andMe to obtain an estimated genetic risk score for coronary artery disease.
-
NEWSBenjamin Cravatt Elected to National Academy of Medicine
Election to the Academy is considered one of the highest honors in the fields of health and medicine.
-
NEWSChemists Use Modified DNA Nucleotides to Create New Materials
Chemists at Scripps Research have demonstrated that they can repurpose DNA to create new substances with possible medical applications.
-
NEWSInstitute Researchers Join National Digital Health Informatics Collaborative
Informatics experts at Scripps Research have been awarded close to $3 million as part of a five-year cooperative agreement to launch the National Center for Data to Health (CD2H).
-
NEWSA New Approach to Cancer Drug Discovery
"This new approach shows promise for identifying previously unrecognized ‘druggable’ targets in cancers that lack effective treatments."
-
NEWSScientists Develop Broad-Spectrum Inhibitors of Influenza Viruses
A team of researchers from Scripps Research and Janssen Pharmaceuticals has devised artificial peptide molecules that neutralize a broad range of influenza virus strains.
-
NEWSResearchers Get a Lead on How to Detect Degenerative Neurological Diseases Sooner
A new peptide probe may hold the key to better understanding amyloid diseases.
-
NEWSCalibr and TSRI Executive Matt Tremblay Receives Biocom Catalyst Award
"Matt’s scientific contributions and business leadership played an important role in establishing Calibr and creating the new model for translational research and innovation represented by the affiliation with TSRI."
-
NEWSScripps Research Study Reveals New Clues to How a Successful HIV Vaccine Could Work
Sugar molecules on HIV envelope protein are likely target for future candidate vaccines.